Cargando…

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study

More stringent blood pressure (BP) goals have led to greater prevalence of apparent resistant hypertension (ARH), yet the long‐term prognostic impact of ARH diagnosed according to these goals in the general population remains unknown. We assessed the prognostic impact of ARH according to contemporar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wijkman, Magnus O., Malachias, Marcus V.B., Claggett, Brian L., Cheng, Susan, Matsushita, Kunihiro, Shah, Amil M., Jhund, Pardeep S., Coresh, Josef, Solomon, Scott D., Vardeny, Orly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678845/ https://www.ncbi.nlm.nih.gov/pubmed/34547175 http://dx.doi.org/10.1111/jch.14269

Ejemplares similares

Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
por: Matsushita, Kunihiro, et al.
Publicado: (2017)

Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
por: Gori, Mauro, et al.
Publicado: (2016)

Cardiac Valve Disease and Prevalent and Incident CKD in Community-Dwelling Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
por: Karandikar, Vedika M., et al.
Publicado: (2022)

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial
por: Vardeny, Orly, et al.
Publicado: (2016)

Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment
por: Ghazi, Lama, et al.
Publicado: (2022)

NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus
por: Malachias, Marcus V. B., et al.
Publicado: (2020)

Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis
por: Teramoto, Kanako, et al.
Publicado: (2020)

A double‐blind, placebo‐controlled trial on the antihypertensive treatment effect of a quadruple single‐pill combination
por: Hu, Lei‐Xiao, et al.
Publicado: (2021)

Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial
por: Sung, Ki‐Chul, et al.
Publicado: (2022)

APOL1 Risk Alleles, Cardiac Markers, and Risk of ESKD in African Americans: The Atherosclerosis Risk in Communities Study
por: Surapaneni, Aditya L., et al.
Publicado: (2020)

Which patients with heart failure should receive specialist palliative care?
por: Campbell, Ross T., et al.
Publicado: (2018)

Socioeconomic Status and Incidence of Hospitalization With Lower‐Extremity Peripheral Artery Disease: Atherosclerosis Risk in Communities Study
por: Vart, Priya, et al.
Publicado: (2017)

Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial
por: Siminiak, Tomasz, et al.
Publicado: (2012)

Ankle-brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study
por: Hua, Simin, et al.
Publicado: (2016)

Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study
por: Ishigami, Junichi, et al.
Publicado: (2018)

Kidney Function and Lipid Levels in Older Adults: The Atherosclerosis Risk in Communities Study
por: Srivastava, Shreya, et al.
Publicado: (2022)

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study
por: Mathews, Lena, et al.
Publicado: (2023)

Association of Peripheral Artery Disease With Incident Atrial Fibrillation: The ARIC (Atherosclerosis Risk in Communities) Study
por: Bekwelem, Wobo, et al.
Publicado: (2018)

NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
por: Malachias, Marcus Vinicius Bolivar, et al.
Publicado: (2022)

Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study
por: Gupta, Deepak K, et al.
Publicado: (2015)

Prognostic Importance of Dyspnea for Cardiovascular Outcomes and Mortality in Persons without Prevalent Cardiopulmonary Disease: The Atherosclerosis Risk in Communities Study
por: Santos, Mario, et al.
Publicado: (2016)

The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study
por: Matsushita, Kunihiro, et al.
Publicado: (2010)

An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
por: Seidelmann, Sara B., et al.
Publicado: (2017)

Bidirectional Association Between Frailty and Cardiac Structure and Function: The Atherosclerosis Risk in Communities Study
por: Ramonfaur, Diego, et al.
Publicado: (2023)

Cardiac Structure and Function and Diabetes‐Related Risk of Death or Heart Failure in Older Adults
por: Inciardi, Riccardo M., et al.
Publicado: (2022)

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications
por: Russell, Mark D, et al.
Publicado: (2023)

Determination of level of self‐reported adherence of antihypertensive drug(s) and its associated factors among patient with hypertension at a tertiary care center
por: Bhusal, Laxman, et al.
Publicado: (2022)

Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk
por: Seidelmann, Sara B., et al.
Publicado: (2018)

Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies
por: van den Brink, Wim, et al.
Publicado: (2013)

When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Implementation Study (IRIS)
por: Gvozdenović, Emilia, et al.
Publicado: (2016)

Diabetes and Risk of Fracture-Related Hospitalization: The Atherosclerosis Risk in Communities Study
por: Schneider, Andrea L.C., et al.
Publicado: (2013)

Proteinuria and Risk of Lower-Extremity Amputation in Patients With Peripheral Artery Disease
por: Shin, Jung-Im, et al.
Publicado: (2019)

Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
por: Lin, Donna S.‐H., et al.
Publicado: (2020)

Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
por: McMurray, John J V, et al.
Publicado: (2014)

Endothelial dysfunction and the risk of heart failure in a community‐based study: the Multi‐Ethnic Study of Atherosclerosis
por: Ärnlöv, Johan, et al.
Publicado: (2020)

Interaction between the NOS3 Gene and Obesity as a Determinant of Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study
por: Bressler, Jan, et al.
Publicado: (2013)

Liver Enzymes and Risk of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
por: Ruban, Angela, et al.
Publicado: (2020)

Association of Undifferentiated Dyspnea in Late Life With Cardiovascular and Noncardiovascular Dysfunction: A Cross-sectional Analysis From the ARIC Study
por: Ramalho, Sergio H. R., et al.
Publicado: (2019)

Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial
por: Cohen-Solal, Alain, et al.
Publicado: (2009)

Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement Outcomes in Left Ventricular Assist Device Patients with Aortic Insufficiency
por: Rali, Aniket S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_54iapt21k3n24ng7vfan3kqccv